Key result
Standardized FXa inhibitor interruption protocol for AF dental procedures linked to 5% bleeding without thromboembolism.
Why the study?
Dental procedures had the highest all-bleeding rate in the PERIXa study, motivating an assessment of bleeding outcomes by dental procedure type, FXa inhibitor, and dosing regimen.
Does a standardized periprocedural interruption protocol for factor Xa inhibitors prevent bleeding and thromboembolic events in patients with atrial fibrillation undergoing dental procedures?
Cohort (n=820)
Yes
Does a standardized periprocedural interruption protocol for factor Xa inhibitors prevent bleeding and thromboembolic events in patients with atrial fibrillation undergoing dental procedures?
A standardized periprocedural interruption protocol for factor Xa inhibitors during dental procedures in patients with atrial fibrillation is associated with very low bleeding risk and excellent thromboembolic safety.
Answers are grounded in this paper and cite their sources.
May guide periprocedural DOAC management in AF; extends observational data but leaves open need for randomized confirmation.
In the PERIXa study, a standardized periprocedural interruption protocol for factor Xa (FXa) inhibitors led to very low major bleeding rates and no thromboembolic events among patients undergoing procedures with minimal to low bleeding risk. However, dental procedures showed the highest all-bleeding rate. This sub-analysis assessed bleeding outcomes by dental procedure type, FXa inhibitor, and dosing regimen to inform tailored anticoagulation strategies in dental practice. This analysis included atrial fibrillation (AF) patients from PERIXa who underwent dental procedures managed with a standardized FXa inhibitor interruption protocol. All-bleeding events—comprising major, clinically relevant non-major, and minor bleeding—as well as thromboembolic events and all-cause death, were evaluated within 30 days. Intraoperative bleeding severity was reported by dentists using standardized questionnaires. Among 820 patients (mean age 71.3 ±9.4 years; 42.0% female) undergoing dental procedures with periprocedural direct oral anticoagulant (DOAC) interruption per the PERIXa protocol, the overall all-bleeding rate was 5.0%, with major bleeding occurring in only 0.2%. No thromboembolic events or deaths were reported. Bleeding risk did not differ significantly by procedure type, DOAC agent, or regimen, though numerically higher all-bleeding rates were observed with implants and combined procedures. Most dentists reported no or manageable bleeding, with no significant variation across groups. Dental procedures performed under the PERIXa protocol were associated with low bleeding risk and excellent thromboembolic safety. These findings support the applicability of the protocol across various dental interventions and DOAC regimens in patients with AF.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) conducted a cohort in Atrial fibrillation undergoing dental procedures (n=820). Standardized factor Xa inhibitor interruption protocol was evaluated on All-bleeding events (composite of major, clinically relevant non-major, and minor bleeding) within 30 days. A standardized periprocedural interruption protocol for factor Xa inhibitors in patients with atrial fibrillation undergoing dental procedures resulted in a low 5.0% overall bleeding rate and no thromboembolic events.
Synapse has enriched 10 related papers. Consider them for comparative context: